Inform the decisions that shape your site plan
Identify additional candidates, assess proposed sites, and focus protocol-specific feasibility.
Identify site candidates
Find investigators and sites with relevant experience and active performance history, including candidates outside your existing sources.
Validate existing site lists
Evaluate known, sponsor-preferred, or recommended candidates using additional operational evidence.
Focus feasibility effort
Prioritize outreach and qualification based on current capacity and available performance signals.
An operational view of site performance
Advarra adds IRB- and clinical trial system-validated insights to the sources you already use, providing evidence that is not available in public profiles, feasibility responses, or your own study history. Operational evidence from tens of thousands of studies and investigators, is organized into four categories: experience, performance, capacity, and quality.
Top Pharmaceutical Identifies Niche Rescue Sites with Advarra
Mid-way through a pivotal Phase III study, a large pharmaceutical team needed to find new sites with investigators experienced in both nephrology and cardiology. Using Advarra’s Site Identification & Feasibility solution, the company compared its outreach list against Advarra’s site and investigator intelligence to uncover a validated, prioritized list of 32 investigators across 29 sites the sponsor had yet to engage. This gave the sponsor confidence in its outreach strategy and a clear path to reach necessary patients for enrollment as soon as possible.
After identifying new high-potential sites, consolidate multiple site lists in one place
- Integrate existing survey tools
- Reduce site burden with automated intelligence
- Gain visibility into survey statuses
Quickly find the right sites, without extra burden
Chief Technology Officer Raghu Punnamraju showcases progress made in feasibility and scalability across Velocity Clinical Research’s global site network, in partnership with Advarra’s technology solutions.
“I think of Advarra as a technology partner with a range of capabilities helping us do clinical research with great partnership. Our feasibilities now are more meaningful and reliable. We’re able to do thirty plus feasibilities in a given day.”
